CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 90 filers reported holding CYTOSORBENTS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $372,127 | -56.4% | 197,940 | -16.8% | 0.52% | -45.5% |
| Q2 2023 | $854,205 | +6.5% | 237,940 | 0.0% | 0.96% | +3.0% |
| Q1 2023 | $801,858 | +108.7% | 237,940 | -4.0% | 0.94% | +99.8% |
| Q4 2022 | $384,307 | +11.7% | 247,940 | -2.0% | 0.47% | +25.1% |
| Q3 2022 | $344,000 | -14.2% | 253,000 | +38.3% | 0.37% | -7.7% |
| Q2 2022 | $401,000 | -32.0% | 183,000 | -1.1% | 0.40% | +12.8% |
| Q1 2022 | $590,000 | -23.9% | 185,000 | 0.0% | 0.36% | +3.8% |
| Q4 2021 | $775,000 | -48.4% | 185,000 | 0.0% | 0.35% | -36.6% |
| Q3 2021 | $1,502,000 | +7.5% | 185,000 | 0.0% | 0.55% | +18.4% |
| Q2 2021 | $1,397,000 | +28.8% | 185,000 | +48.0% | 0.46% | +9.8% |
| Q1 2021 | $1,085,000 | – | 125,000 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 675,000 | $918,000 | 1.02% |
| Sargent Investment Group, LLC | 1,108,233 | $2,028,000 | 0.63% |
| Skylands Capital, LLC | 2,347,034 | $3,192,000 | 0.52% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 253,000 | $344,000 | 0.37% |
| Avenir Corp | 2,314,854 | $3,148,000 | 0.33% |
| Granahan Investment Management | 1,511,029 | $2,055,000 | 0.07% |
| ACT CAPITAL MANAGEMENT, LLC | 35,000 | $48,000 | 0.07% |
| Winning Points Advisors, LLC | 22,900 | $33,000 | 0.04% |
| Cowen Prime Advisors LLC | 42,200 | $57,000 | 0.03% |
| Seelaus Asset Management LLC | 23,900 | $33,000 | 0.03% |